Tatva Chintan Pharma Chem Limited has intimated the stock exchanges of a scheduled meeting with investors, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will be participating in a one-to-one meeting with Motilal Oswal AMC. The meeting is scheduled for 31 July 2026 and will be conducted as a virtual meeting.
The disclosure includes a clear statement that the company will be referring only to publicly available information for discussions during this interaction. It explicitly confirms that no confidential or unpublished price sensitive information (UPSI) will be shared during the meeting.
The intimation is noted to be subject to change. The information has also been made available on the company's website at www.tatvachintan.com.
The communication was signed by Ishwar Ramanbhai Nayi, Company Secretary and Compliance Officer (Membership No.: A37444), on behalf of Tatva Chintan Pharma Chem Limited.